What Does Pet Imaging Add to Conventional Staging of Head and Neck Cancer Patients?

International Journal of Radiation Oncology Biology Physics

Volumn 68, Issue 2, 2007, Pages 383-387

  Pohar, Surjeet ^a,b   Brown, Robert ^a   Newman, Nancy ^a   Koniarczyk, Michael ^a   Hsu, Jack ^a   Feiglin, David ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Head and neck carcinoma; PET imaging

Indexed keywords

COMPUTERIZED TOMOGRAPHY; DISEASES; ENDOSCOPY; GLUCOSE; PATHOLOGY; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; TUMORS;

CLINICAL STAGING; HEAD AND NECK CARCINOMA; PET IMAGING;

ONCOLOGY;

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; ENDOSCOPY; FEMALE; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CANCER; LARYNX CANCER; MALE; MEDICAL RECORD REVIEW; MOUTH CANCER; NECK DISSECTION; NOSE CAVITY CANCER; OROPHARYNX CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; THORAX RADIOGRAPHY;

CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; NECK DISSECTION; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34247848017     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.12.044     Document Type: Article

References (14)

1. 18F-FDG PET: A comparison with conventional methods. Eur J Nucl Med 28 (2001) 816-821
2. 18F fluorodeoxyglucose positron emission tomography compared with physical examination and conventional imaging modalities. J Oral Maxillofac Surg 61 (2003) 1022-1029
3. Schecter N., Gillenwater A., Byers R., et al. Can positron emission tomography improve the quality of care for head and neck cancer patients?. Int J Radiat Oncol Biol Phys 51 (2001) 4-9
4. Gregoire V. Is there any future in radiotherapy planning without the use of PET: Unraveling the myth.... Radiother Oncol 73 (2004) 261-263
5. Frank S.J., Chao K.S., Schwartz D.L., et al. Technology insight: PET and PET/CT in head and neck tumor staging and radiation therapy planning. Natl Clin Pract Oncol 10 (2005) 526-533
6. Vermeersch H., Loose D., Ham H., et al. Nuclear medicine imaging for the assessment of primary and recurrent head and neck carcinoma using routinely available tracers. Eur J Nucl Med Mol Imaging 30 (2003) 1689-1700
7. 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 25 (1998) 1255-1260
8. Schwartz D., Ford E., Rajendran J., et al. FDG-PET/CT imaging for preradiotherapy staging of head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 129-136
9. Stuckensen T., Kovacs A.F., Adams S., et al. Staging of the neck in patients with oral cavity squamous cell carcinomas: A prospective comparison of PET, ultrasound, CT and MRI. J Craniomaxillofac Surg 28 (2000) 319-324
10. Jaeschke R., Guyatt G., and Sackett D. Users guide to the medical literature-III. How to use an article about a diagnostic test-B. Are the results of the study valid?. JAMA 271 (1994) 389-391
11. Jaeschke R., Guyatt G., and Sackett D. Users guide to the medical literature-III. How to use an article about a diagnostic test-B. What are the results and will they help me in caring for my patients?. JAMA 271 (1994) 703-707
12. Jemal A., Taylor M., Ward E., et al. Cancer Statistics 2005. CA Cancer J Clin 55 (2005) 10-30
13. Centers for Medicare and Medicaid Services, 2005 Fee Schedule, Upstate New York Division. Available at: http://www.umd.nycpic.com.
14. 18F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 20 (2002) 4199-4208